The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy

The Wilms tumor gene WT1 is a useful marker of clonal hematopoiesis and it has been shown to be a good marker of residual disease and it reflects the response to therapy. Although myelofibrosis is characterized by mutations of JAK2 and calreticulin (CALR), these mutations are not useful to monitor r...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Med
Главные авторы: Gallo, Daniela, Nicoli, Paolo, Calabrese, Chiara, Gaidano, Valentina, Petiti, Jessica, Rosso, Valentina, Signorino, Elisabetta, Carturan, Sonia, Bot‐Sartor, Giada, Volpe, Gisella, Frassoni, Francesco, Saglio, Giuseppe, Cilloni, Daniela
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Commentary
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867666/
https://ncbi.nlm.nih.gov/pubmed/27167495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.735
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы